Fig. 3From: Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastomaSurvival curves. a Overall survival and progression-free survival b according to baseline cfDNA concentration below or above the median. OS (c) and PFS (d) according to the increase or decrease of cfDNA between baseline and pre-RT-TMZBack to article page